133 related articles for article (PubMed ID: 11567992)
1. Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells.
Cohen JL; Boyer O; Klatzmann D
Blood; 2001 Oct; 98(7):2071-6. PubMed ID: 11567992
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease.
Litvinova E; Maury S; Boyer O; Bruel S; Benard L; Boisserie G; Klatzmann D; Cohen JL
Blood; 2002 Sep; 100(6):2020-5. PubMed ID: 12200361
[TBL] [Abstract][Full Text] [Related]
3. Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease.
Maury S; Litvinova E; Boyer O; Benard L; Bruel S; Klatzmann D; Cohen JL
Gene Ther; 2002 Feb; 9(3):201-7. PubMed ID: 11859423
[TBL] [Abstract][Full Text] [Related]
4. Regulation of alloresponses after bone marrow transplantation using donor T cells expressing a thymidine kinase suicide gene.
Drobyski WR; Gendelman M
Leuk Lymphoma; 2002 Oct; 43(10):2011-6. PubMed ID: 12481900
[TBL] [Abstract][Full Text] [Related]
5. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
6. Immunological defects after suicide gene therapy of experimental graft-versus-host disease.
Cohen JL; Lacroix-Desmazes S; Charlotte F; Lejeune L; Martin PJ; Klatzmann D; Boyer O
Hum Gene Ther; 1999 Nov; 10(16):2701-7. PubMed ID: 10566898
[TBL] [Abstract][Full Text] [Related]
7. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.
Tiberghien P; Ferrand C; Lioure B; Milpied N; Angonin R; Deconinck E; Certoux JM; Robinet E; Saas P; Petracca B; Juttner C; Reynolds CW; Longo DL; Hervé P; Cahn JY
Blood; 2001 Jan; 97(1):63-72. PubMed ID: 11133743
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene.
Garin MI; Garrett E; Tiberghien P; Apperley JF; Chalmers D; Melo JV; Ferrand C
Blood; 2001 Jan; 97(1):122-9. PubMed ID: 11133751
[TBL] [Abstract][Full Text] [Related]
9. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes.
Bondanza A; Valtolina V; Magnani Z; Ponzoni M; Fleischhauer K; Bonyhadi M; Traversari C; Sanvito F; Toma S; Radrizzani M; La Seta-Catamancio S; Ciceri F; Bordignon C; Bonini C
Blood; 2006 Mar; 107(5):1828-36. PubMed ID: 16293601
[TBL] [Abstract][Full Text] [Related]
10. Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene.
Drobyski WR; Morse HC; Burns WH; Casper JT; Sandford G
Blood; 2001 Apr; 97(8):2506-13. PubMed ID: 11290616
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.
Rettig MP; Ritchey JK; Prior JL; Haug JS; Piwnica-Worms D; DiPersio JF
J Immunol; 2004 Sep; 173(6):3620-30. PubMed ID: 15356106
[TBL] [Abstract][Full Text] [Related]
12. Prolonged allograft survival through conditional and specific ablation of alloreactive T cells expressing a suicide gene.
Thomas-Vaslin V; Bellier B; Cohen JL; Boyer O; Raynal-Raschilas N; Glotz D; Klatzmann D
Transplantation; 2000 May; 69(10):2154-61. PubMed ID: 10852616
[TBL] [Abstract][Full Text] [Related]
13. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?
Tiberghien P; Reynolds CW; Keller J; Spence S; Deschaseaux M; Certoux JM; Contassot E; Murphy WJ; Lyons R; Chiang Y
Blood; 1994 Aug; 84(4):1333-41. PubMed ID: 8049449
[TBL] [Abstract][Full Text] [Related]
14. Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting.
Contassot E; Ferrand C; Angonin R; Cohen JL; de Carvalho Bittencourt M; Lorchel F; Laithier V; Cahn JY; Klatzmann D; Herve P; Tiberghien P
Transplantation; 2000 Feb; 69(4):503-8. PubMed ID: 10708102
[TBL] [Abstract][Full Text] [Related]
15. Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
Kornblau SM; Aycox PG; Stephens C; McCue LD; Champlin RE; Marini FC
Exp Hematol; 2007 May; 35(5):842-53. PubMed ID: 17577932
[TBL] [Abstract][Full Text] [Related]
16. Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
Kornblau SM; Stiouf I; Snell V; Przepiorka D; Stephens LC; Champlin R; Marini FC
Cancer Res; 2001 Apr; 61(8):3355-60. PubMed ID: 11309292
[TBL] [Abstract][Full Text] [Related]
17. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
Weijtens M; van Spronsen A; Hagenbeek A; de Weger R; Martens A
Exp Hematol; 2004 Oct; 32(10):962-9. PubMed ID: 15504552
[TBL] [Abstract][Full Text] [Related]
18. TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy.
Preuss E; Treschow A; Newrzela S; Brücher D; Weber K; Felldin U; Alici E; Gahrton G; von Laer D; Dilber MS; Fehse B
Hum Gene Ther; 2010 Aug; 21(8):929-41. PubMed ID: 20201626
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
[TBL] [Abstract][Full Text] [Related]
20. Genetically engineered T-cells expressing a ganciclovir-sensitive HSV-tk suicide gene for the prevention of GvHD.
Mailly L; Leboeuf C; Tiberghien P; Baumert T; Robinet E
Curr Opin Investig Drugs; 2010 May; 11(5):559-70. PubMed ID: 20419602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
